Our mission is to advance precision medicine for patients with kidney diseases and kidney transplant recipients. We aim to develop and validate liquid biopsy techniques and predictive biomarkers as non-invasive tools, for chronic kidney disease and kidney transplant management, by sharing and assaying biological specimens through a collaborative effort involving experts from around the world. The active projects available below demonstrate our unwavering passion to advance research and development.
The main projects at the Azzi Lab are the PKT, BK, and IBS/N-IBS study. See the details for each below.